{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T03:28:30Z","timestamp":1790998110811,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","heartfailure.onlinejacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Heart Failure"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.jchf.2017.10.009","type":"journal-article","created":{"date-parts":[[2017,11,27]],"date-time":"2017-11-27T20:00:59Z","timestamp":1511812859000},"page":"869-878","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Evolving Areas in Heart Transplantation"],"prefix":"10.1016","volume":"5","author":[{"given":"Brittany N.","family":"Weber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon A.","family":"Kobashigawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael M.","family":"Givertz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchf.2017.10.009_bib1","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1600-6143.2010.03016.x","article-title":"A\u00a0phase III study of belatacept versus cyclosporine in kidney transplants from extended criteria donors (BENEFIT-EXT study)","volume":"10","author":"Durrbach","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jchf.2017.10.009_bib2","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1111\/j.1600-6143.2009.02720.x","article-title":"Calcineurin-inhibitor-free immunosuppression based on the JAK inhibitor CP-690,550: a pilot study in de novo kidney allograft recipients","volume":"9","author":"Busque","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jchf.2017.10.009_bib3","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1111\/ajt.13181","article-title":"Evaluation of the effect of tofacitinib exposure on outcomes in kidney transplant patients","volume":"15","author":"Vincenti","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jchf.2017.10.009_bib4","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1111\/ajt.12251","article-title":"Efficacy of sotrastaurin plus tacrolimus after de novo kidney transplantation: randomized, phase II trial results","volume":"13","author":"Russ","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jchf.2017.10.009_bib5","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1097\/TP.0000000000000741","article-title":"A\u00a0phase I\/II trial of the interleukin-6 receptor-specific humanized monoclonal (tocilizumab)\u00a0+ intravenous immunoglobulin in difficult to desensitize patients","volume":"99","author":"Vo","year":"2015","journal-title":"Transplantation"},{"key":"10.1016\/j.jchf.2017.10.009_bib6","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.healun.2012.09.016","article-title":"Treatment of hyperacute antibody-mediated lung allograft rejection with eculizumab","volume":"31","author":"Dawson","year":"2012","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.jchf.2017.10.009_bib7","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1111\/j.1600-6143.2011.03757.x","article-title":"Terminal complement inhibition decreases antibody-mediated rejection in sensitized renal transplant recipients","volume":"11","author":"Stegall","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jchf.2017.10.009_bib8","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1056\/NEJMoa1612567","article-title":"IgG endopeptidase in highly sensitized patients undergoing transplantation","volume":"377","author":"Jordan","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jchf.2017.10.009_bib9","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.healun.2016.08.017","article-title":"The Registry of the International Society for Heart and Lung Transplantation: Thirty-third Adult Heart Transplantation Report-2016; Focus Theme: Primary Diagnostic Indications for Transplant","volume":"35","author":"Lund","year":"2016","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.jchf.2017.10.009_bib10","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.healun.2016.09.016","article-title":"Post-transplant surveillance for acute rejection and allograft vasculopathy by echocardiography: usefulness of myocardial velocity and deformation imaging","volume":"36","author":"Dandel","year":"2017","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.jchf.2017.10.009_bib11","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1093\/ehjci\/jev139","article-title":"European Association of Cardiovascular Imaging\/Cardiovascular Imaging Department of the Brazilian Society of Cardiology recommendations for the use of cardiac imaging to assess and follow patients after heart transplantation","volume":"16","author":"Badano","year":"2015","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.jchf.2017.10.009_bib12","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1111\/ajt.14180","article-title":"Testing the efficacy of contrast-enhanced ultrasound in detecting transplant rejection using a murine model of heart transplantation","volume":"17","author":"Fischer","year":"2017","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jchf.2017.10.009_bib13","doi-asserted-by":"crossref","first-page":"e132","DOI":"10.1097\/TP.0000000000000618","article-title":"Use of [18F]FDG PET to monitor the development of cardiac allograft rejection","volume":"99","author":"Daly","year":"2015","journal-title":"Transplantation"},{"key":"10.1016\/j.jchf.2017.10.009_bib14","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.ejcts.2009.12.014","article-title":"Imaging of acute heart-transplant rejection using 99m-Technetium labelled oligonucleotides against interleukin-2 mRNA in rats","volume":"37","author":"Gierthmuehlen","year":"2010","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.jchf.2017.10.009_bib15","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1038\/nm1201-1347","article-title":"Annexin-V imaging for noninvasive detection of cardiac allograft rejection","volume":"7","author":"Narula","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.jchf.2017.10.009_bib16","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1161\/CIRCIMAGING.111.971101","article-title":"Cardiac magnetic resonance T2 mapping in the monitoring and follow-up of acute cardiac transplant rejection: a pilot study","volume":"5","author":"Usman","year":"2012","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jchf.2017.10.009_bib17","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.healun.2014.12.020","article-title":"Correlation of cardiovascular magnetic resonance imaging findings and endomyocardial biopsy results in patients undergoing screening for heart transplant rejection","volume":"34","author":"Butler","year":"2015","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.jchf.2017.10.009_bib18","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/eurjhf\/hfp174","article-title":"Diagnostic performance of multisequential cardiac magnetic resonance imaging in acute cardiac allograft rejection","volume":"12","author":"Taylor","year":"2010","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2017.10.009_bib19","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.jcmg.2009.01.013","article-title":"Noninvasive evaluation of cardiac allograft rejection by cellular and functional cardiac magnetic resonance","volume":"2","author":"Wu","year":"2009","journal-title":"J\u00a0Am Coll Cardiol Img"},{"key":"10.1016\/j.jchf.2017.10.009_bib20","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.healun.2003.07.017","article-title":"Heart allograft rejection: detection with breath alkanes in low levels (the HARDBALL study)","volume":"23","author":"Phillips","year":"2004","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.jchf.2017.10.009_bib21","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.healun.2010.05.034","article-title":"The International Society of Heart and Lung Transplantation guidelines for the care of heart transplant recipients","volume":"29","author":"Costanzo","year":"2010","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.jchf.2017.10.009_bib22","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1600-6143.2005.01175.x","article-title":"Noninvasive discrimination of rejection in cardiac allograft recipients using gene expression profiling","volume":"6","author":"Deng","year":"2006","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jchf.2017.10.009_bib23","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1056\/NEJMoa0912965","article-title":"Gene-expression profiling for rejection surveillance after cardiac transplantation","volume":"362","author":"Pham","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jchf.2017.10.009_bib24","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1016\/j.transproceed.2015.08.035","article-title":"Donor-derived cell-free DNA is a novel universal biomarker for allograft rejection in solid organ transplantation","volume":"47","author":"Beck","year":"2015","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jchf.2017.10.009_bib25","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jacc.2016.04.033","article-title":"Allograft vasculopathy: the Achilles\u2019 heel of heart transplantation","volume":"68","author":"Chih","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2017.10.009_bib26","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.healun.2010.05.017","article-title":"International Society for Heart and Lung Transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopathy\u20132010","volume":"29","author":"Mehra","year":"2010","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.jchf.2017.10.009_bib27","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1161\/01.CIR.100.5.509","article-title":"Diagnostic and prognostic value of serial dobutamine stress echocardiography for noninvasive assessment of cardiac allograft vasculopathy: a comparison with coronary angiography and intravascular ultrasound","volume":"100","author":"Spes","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2017.10.009_bib28","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s12350-009-9166-x","article-title":"Diagnostic and prognostic value of myocardial perfusion gated SPECT in orthotopic heart transplant recipients","volume":"17","author":"Manrique","year":"2010","journal-title":"J\u00a0Nucl Cardiol"},{"key":"10.1016\/j.jchf.2017.10.009_bib29","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1161\/CIRCIMAGING.114.002184","article-title":"Prognostic value of rubidium-82 positron emission tomography in patients after heart transplant","volume":"7","author":"Mc Ardle","year":"2014","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.jchf.2017.10.009_bib30","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/j.athoracsur.2015.10.017","article-title":"Heart xenotransplantation: historical background, experimental progress, and clinical prospects","volume":"101","author":"Murthy","year":"2016","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.jchf.2017.10.009_bib31","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1126\/science.1078942","article-title":"Production of alpha 1,3-galactosyltransferase-deficient pigs","volume":"299","author":"Phelps","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.jchf.2017.10.009_bib32","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/imm.12107","article-title":"Human dominant-negative class II transactivator transgenic pigs\u2014effect on the human anti-pig T-cell immune response and immune status","volume":"140","author":"Hara","year":"2013","journal-title":"Immunology"},{"key":"10.1016\/j.jchf.2017.10.009_bib33","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/ajt.12562","article-title":"One-year heterotopic cardiac xenograft survival in a pig to baboon model","volume":"14","author":"Mohiuddin","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jchf.2017.10.009_bib34","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/xen.12019","article-title":"Double knockout pigs deficient in N-glycolylneuraminic acid and galactose \u03b1-1,3-galactose reduce the humoral barrier to xenotransplantation","volume":"20","author":"Lutz","year":"2013","journal-title":"Xenotransplantation"},{"key":"10.1016\/j.jchf.2017.10.009_bib35","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1126\/science.1164680","article-title":"Evidence for cardiomyocyte renewal in humans","volume":"324","author":"Bergmann","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.jchf.2017.10.009_bib36","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/nrcardio.2014.9","article-title":"Cell therapy for cardiac repair\u2014lessons from clinical trials","volume":"11","author":"Behfar","year":"2014","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jchf.2017.10.009_bib37","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1161\/CIRCRESAHA.116.304386","article-title":"Meta-analysis of cell therapy trials for patients with heart failure","volume":"116","author":"Fisher","year":"2015","journal-title":"Circ Res"},{"key":"10.1016\/j.jchf.2017.10.009_bib38","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/j.jacc.2013.02.071","article-title":"Cardiopoietic stem cell therapy in heart failure: the C-CURE (Cardiopoietic stem Cell therapy in heart failURE) multicenter randomized trial with lineage-specified biologics","volume":"61","author":"Bartunek","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2017.10.009_bib39","first-page":"648","article-title":"Cardiopoietic cell therapy for advanced ischaemic heart failure: results at 39 weeks of the prospective, randomized, double blind, sham-controlled CHART-1 clinical trial","volume":"38","author":"Bartunek","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jchf.2017.10.009_bib40","doi-asserted-by":"crossref","DOI":"10.1002\/ejhf.898","article-title":"Benefit of cardiopoietic mesenchymal stem cell therapy on left ventricular remodelling: results from the Congestive Heart Failure Cardiopoietic Regenerative Therapy (CHART-1) study","author":"Teerlink","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2017.10.009_bib41","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1016\/S0140-6736(16)30137-4","article-title":"Ixmyelocel-T for patients with ischaemic heart failure: a prospective randomised double-blind trial","volume":"387","author":"Patel","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.jchf.2017.10.009_bib42","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.jacc.2017.06.012","article-title":"Overcoming the roadblocks to cardiac cell therapy using tissue engineering","volume":"70","author":"Yanamandala","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2017.10.009_bib43","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1161\/CIRCULATIONAHA.116.024145","article-title":"Defined engineered human myocardium with advanced maturation for applications in heart failure modeling and repair","volume":"135","author":"Tiburcy","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2017.10.009_bib44","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.healun.2015.10.003","article-title":"Seventh INTERMACS annual report: 15,000 patients and counting","volume":"34","author":"Kirklin","year":"2015","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.jchf.2017.10.009_bib45","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.healun.2015.10.031","article-title":"Hospital readmissions after discharge to home with the Total Artificial Heart Freedom driver: readmission reasons, clinical outcomes, and health care costs","volume":"35","author":"Quader","year":"2016","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.jchf.2017.10.009_bib46","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1111\/jocs.12644","article-title":"Total artificial hearts\u2014past, current, and future","volume":"30","author":"Fox","year":"2015","journal-title":"J\u00a0Card Surg"}],"container-title":["JACC: Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177917307060?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177917307060?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T02:19:29Z","timestamp":1543630769000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213177917307060"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":46,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S2213177917307060"],"URL":"https:\/\/doi.org\/10.1016\/j.jchf.2017.10.009","relation":{},"ISSN":["2213-1779"],"issn-type":[{"value":"2213-1779","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evolving Areas in Heart Transplantation","name":"articletitle","label":"Article Title"},{"value":"JACC: Heart Failure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchf.2017.10.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}